While TSA effectively inhibits HDAC6 and reduces cancer cell migration speed (Fig. 4Db), its broad inhibition of multiple HDAC isoforms raises concerns about off-target and pleiotropic effects. The gene discussed is HDAC9; the disease is cancer.